Close Menu

NEW YORK (GenomeWeb) – PlexBio today announced plans to expand its collaboration with Denka to include the codevelopment of a molecular diagnostic platform for infectious disease testing.

The new system will leverage PlexBio's multiplex πCode MicroDisc technology and initially focus on tests for sepsis and multidrug resistance. A full menu of assays for infectious disease is also planned, Taipei, Taiwan-based PlexBio said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.